Literature DB >> 8432584

Escherichia coli heat-labile toxin subunit B fusions with Streptococcus sobrinus antigens expressed by Salmonella typhimurium oral vaccine strains: importance of the linker for antigenicity and biological activities of the hybrid proteins.

E K Jagusztyn-Krynicka1, J E Clark-Curtiss, R Curtiss.   

Abstract

A set of vectors possessing the genes for aspartate semialdehyde dehydrogenase (asd) and the B subunit of the heat-labile enterotoxin of Escherichia coli (LT-B) has been developed. These vectors allow operon or gene fusions of foreign gene epitopes at the C-terminal end of LT-B. Two groups of vectors have been constructed with and without leader sequences to facilitate placing of the foreign antigen in different cell compartments. Two Streptococcus sobrinus genes coding for principal colonization factors, surface protein antigen A (SpaA), and dextranase (Dex), have been fused into the 3' end of the LT-B gene. Resulting protein fusions of approximately 120 to 130 kDa are extremely well recognized by antibodies directed against both SpaA and Dex as well as against LT-B domains and retain the enzymatic activity of dextranase and the biological activity of LT-B in that they bind to GM1 gangliosides. Maximum antigenicity was obtained with the vector possessing an intervening linker of at least six amino acids with two proline residues. Some of the fusion proteins also exhibited another property of LT-B in that they were exported into the periplasm where they oligomerized. LT-B-SpaA and LT-B-Dex hybrid proteins are expressed stably and at a high level in avirulent Salmonella typhimurium vaccine strains which are being used to investigate their immunogenicity and types of induced immune responses. The fusion vectors will also be useful for production and purification of LT-B fusion antigens to be used and evaluated in other vaccine compositions.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8432584      PMCID: PMC302832          DOI: 10.1128/iai.61.3.1004-1015.1993

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  43 in total

1.  Recombinant cholera toxin B subunit and gene fusion proteins for oral vaccination.

Authors:  J Sanchez; S Johansson; B Löwenadler; A M Svennerholm; J Holmgren
Journal:  Res Microbiol       Date:  1990 Sep-Oct       Impact factor: 3.992

2.  Cistrons encoding Escherichia coli heat-labile toxin.

Authors:  W S Dallas; D M Gill; S Falkow
Journal:  J Bacteriol       Date:  1979-09       Impact factor: 3.490

3.  Immunological cross-reactivity between a heat-labile enterotoxin(s) of Escherichia coli and subunits of Vibrio cholerae enterotoxin.

Authors:  J D Clements; R A Finkelstein
Journal:  Infect Immun       Date:  1978-09       Impact factor: 3.441

4.  Mutants in transmission of chemotactic signals from two independent receptors of E. coli.

Authors:  G L Hazelbauer; S Harayama
Journal:  Cell       Date:  1979-03       Impact factor: 41.582

5.  A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels.

Authors:  C M Tsai; C E Frasch
Journal:  Anal Biochem       Date:  1982-01-01       Impact factor: 3.365

6.  A rapid alkaline extraction method for the isolation of plasmid DNA.

Authors:  H C Birnboim
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

7.  Cholera toxin B subunit as a carrier protein to stimulate a mucosal immune response.

Authors:  S J McKenzie; J F Halsey
Journal:  J Immunol       Date:  1984-10       Impact factor: 5.422

8.  Vaccine for enterotoxigenic Escherichia coli based on synthetic heat-stable toxin crossed-linked to the B subunit of heat-labile toxin.

Authors:  F A Klipstein; R F Engert; J D Clements; R A Houghten
Journal:  J Infect Dis       Date:  1983-02       Impact factor: 5.226

9.  Antitoxic immunity to cholera in dogs immunized orally with cholera toxin.

Authors:  N F Pierce; W C Cray; P F Engel
Journal:  Infect Immun       Date:  1980-02       Impact factor: 3.441

10.  Assembly in vivo of enterotoxin from Escherichia coli: formation of the B subunit oligomer.

Authors:  T R Hirst; S J Hardy; L L Randall
Journal:  J Bacteriol       Date:  1983-01       Impact factor: 3.490

View more
  10 in total

Review 1.  Enteric pathogens as vaccine vectors for foreign antigen delivery.

Authors:  Camille N Kotton; Elizabeth L Hohmann
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

Review 2.  Bifunctional xylanases and their potential use in biotechnology.

Authors:  Rakhee Khandeparker; Mondher Th Numan
Journal:  J Ind Microbiol Biotechnol       Date:  2008-03-26       Impact factor: 3.346

3.  Salivary, nasal, genital, and systemic antibody responses in monkeys immunized intranasally with a bacterial protein antigen and the Cholera toxin B subunit.

Authors:  M W Russell; Z Moldoveanu; P L White; G J Sibert; J Mestecky; M Michalek S
Journal:  Infect Immun       Date:  1996-04       Impact factor: 3.441

4.  Comparison of the abilities of different attenuated Salmonella typhimurium strains to elicit humoral immune responses against a heterologous antigen.

Authors:  S J Dunstan; C P Simmons; R A Strugnell
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

5.  Construction, expression, and immunogenicity of the Schistosoma mansoni P28 glutathione S-transferase as a genetic fusion to tetanus toxin fragment C in a live Aro attenuated vaccine strain of Salmonella.

Authors:  C M Khan; B Villarreal-Ramos; R J Pierce; G Riveau; R Demarco de Hormaeche; H McNeill; T Ali; N Fairweather; S Chatfield; A Capron
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-08       Impact factor: 11.205

6.  Protection against lethal leptospirosis after vaccination with LipL32 coupled or coadministered with the B subunit of Escherichia coli heat-labile enterotoxin.

Authors:  André A Grassmann; Samuel R Félix; Carolina Ximendes dos Santos; Marta G Amaral; Amilton C P Seixas Neto; Michel Q Fagundes; Fabiana K Seixas; Everton F da Silva; Fabricio R Conceição; Odir A Dellagostin
Journal:  Clin Vaccine Immunol       Date:  2012-02-29

7.  Functional pentameric formation via coexpression of the Escherichia coli heat-labile enterotoxin B subunit and its fusion protein subunit with a neutralizing epitope of ApxIIA exotoxin improves the mucosal immunogenicity and protection against challenge by Actinobacillus pleuropneumoniae.

Authors:  Jung-Mi Kim; Seung-Moon Park; Jung-Ae Kim; Jin-Ah Park; Min-Hee Yi; Nan-Sun Kim; Jong-Lye Bae; Sung Goo Park; Yong-Suk Jang; Moon-Sik Yang; Dae-Hyuk Kim
Journal:  Clin Vaccine Immunol       Date:  2011-10-26

8.  Production of a fusion protein consisting of the enterotoxigenic Escherichia coli heat-labile toxin B subunit and a tuberculosis antigen in Arabidopsis thaliana.

Authors:  M M Rigano; M L Alvarez; J Pinkhasov; Y Jin; F Sala; C J Arntzen; A M Walmsley
Journal:  Plant Cell Rep       Date:  2003-10-10       Impact factor: 4.570

9.  Comparative immunological evaluation of recombinant Salmonella Typhimurium strains expressing model antigens as live oral vaccines.

Authors:  Song-yue Zheng; Bin Yu; Ke Zhang; Min Chen; Yan-Hong Hua; Shuofeng Yuan; Rory M Watt; Bo-Jian Zheng; Kwok-Yung Yuen; Jian-Dong Huang
Journal:  BMC Immunol       Date:  2012-09-26       Impact factor: 3.615

10.  A continuous epitope from transmissible gastroenteritis virus S protein fused to E. coli heat-labile toxin B subunit expressed by attenuated Salmonella induces serum and secretory immunity.

Authors:  C Smerdou; I M Anton; J Plana; R Curtiss; L Enjuanes
Journal:  Virus Res       Date:  1996-03       Impact factor: 3.303

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.